CERo Therapeutics Holdings, Inc.
CERO
$5.40
-$0.10-1.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.30M | 5.20M | 3.25M | 3.38M | 3.65M |
| Total Receivables | -- | -- | -- | -- | 87.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 443.90K | 564.50K | 274.70K | 334.30K | 511.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 500.00K | -- | 187.00K | -- | -- |
| Total Current Assets | 4.25M | 5.77M | 3.71M | 3.71M | 4.25M |
|
|
|||||
| Total Current Assets | 4.25M | 5.77M | 3.71M | 3.71M | 4.25M |
| Net Property, Plant & Equipment | 1.46M | 1.72M | 1.99M | 2.28M | 2.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 500.00K | 500.00K | 500.00K | 500.00K | 550.00K |
| Total Assets | 6.20M | 7.99M | 6.21M | 6.49M | 7.37M |
|
|
|||||
| Total Accounts Payable | 6.21M | 6.38M | 4.51M | 6.67M | 6.35M |
| Total Accrued Expenses | 365.10K | 469.70K | 1.91M | 1.69M | 1.16M |
| Short-term Debt | -- | -- | -- | 102.30K | 253.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 934.30K | 905.00K | 876.40K | 931.00K | 821.30K |
| Total Finance Division Other Current Liabilities | 105.50K | 105.50K | 105.50K | 30.00K | 200.00K |
| Total Other Current Liabilities | 105.50K | 105.50K | 105.50K | 30.00K | 200.00K |
| Total Current Liabilities | 7.62M | 7.86M | 7.40M | 9.42M | 8.78M |
|
|
|||||
| Total Current Liabilities | 7.62M | 7.86M | 7.40M | 9.42M | 8.78M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 102.30K | 253.20K |
| Capital Leases | 218.30K | 461.60K | 699.10K | 771.50K | 1.07M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.84M | 8.32M | 8.10M | 10.19M | 9.85M |
|
|
|||||
| Common Stock & APIC | 71.31M | 73.35M | 67.14M | 66.38M | 57.64M |
| Retained Earnings | -81.44M | -76.02M | -70.92M | -71.59M | -67.36M |
| Treasury Stock & Other | -78.80K | -78.80K | -1.30M | -2.07M | -2.20M |
| Total Common Equity | -10.21M | -2.76M | -5.07M | -7.29M | -11.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 8.57M | 2.43M | 3.18M | 3.58M | 9.44M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 8.57M | 2.43M | 3.18M | 3.58M | 9.44M |
|
|
|||||
| Total Common Equity | -10.21M | -2.76M | -5.07M | -7.29M | -11.92M |
| Total Preferred Equity | 8.57M | 2.43M | 3.18M | 3.58M | 9.44M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.63M | -329.40K | -1.89M | -3.70M | -2.48M |
|
|
|||||